TRAF3IP2 and systemic lupus erythematosus: To test this hypothesis, we assessed whether 9 weeks of vitamin D3 restriction or supplementation was sufficient to alter the Act1-/- autoimmune phenotype; specifically, the development of SLE-like characteristics.